St. Jude Cardiovascular Access Sales Jump 107% In Q1 To $23 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Strong U.S. sales of the 6 Fr version of St. Jude Medical's Angio-Seal hemostatic puncture closure system since its introduction in mid-March, and "the expansion and focus of cardiology vascular access selling efforts in the U.S.," were the driving forces behind a 107% jump in first quarter cardiovascular access product sales to $23 mil.